Civica Rx at a year old strikes new deal for meds in short supply

Syringe and vial
Civica Rx, the hospital-backed contract manufacturing group, has struck a new deal for products often hard for hospitals to come by. (Pixabay)

Civica Rx, which last week hit its first anniversary, continues to strike deals that will help it to battle shortages and high costs for its healthcare members. 

The latest is an agreement with Exela Pharma Sciences to provide sodium bicarbonate, a drug that healthcare providers have had some trouble getting in recent years, to hospitals in the U.S. 

“Sodium bicarbonate is a medicine that is a staple on hospital crash carts and often used for emergency resuscitations. No hospital or patient should ever have to go without it,” Civica Rx CEO Martin VanTrieste said in a statement


Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

Civica Rx was created last September by healthcare groups to help hospitals, which have battled drug shortages and price hikes for years. The supply interruptions sometimes force hospitals to ration drugs or make decisions on which patients get certain drugs.

Since being formed, it has struck deals to provide products with a number of contractors including Hikma for more than a dozen injectables and Xellia Pharmaceuticals to produce antibiotics.

Suggested Articles

China is quickly getting back up to speed with API production but reports freight bottlenecks are slowing deliveries.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

As flights from China contract and prices double, the logistics of getting products out of China is a major challenge.